... Health Secretary Sajid Javid said two studies suggesting omicron carries a significantly lower risk of hospitalization than the previously dominant delta strain was “encouraging news.” But he said it was “not very clear yet ... by how much that risk is reduced.” ...
This authorization is more limited than one on Wednesday for a Pfizer pill. The FDA authorized the Merck pill, developed with Ridgeback Biotherapeutics, for high-risk adults "for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate."
SEATTLE — Early in the pandemic, many people seized on the hope that Covid-19 could be stopped in its tracks and buried for good once vaccines rolled out.
But hope for a zero-Covid country fizzled for most scientists long ago.
“Everyone has stopped talking about getting rid of Covid,” Dr. Elizabeth Halloran, an epidemiologist at the Fred Hutchinson Cancer Research Center in Seattle, said of her fellow researchers. “It’s not going away, and that means it’s going to be endemic.”
(CNN) Two new preprint papers add to the growing evidence that the Omicron coronavirus variant may be less likely to cause severe disease and hospitalization compared to the Delta variant.
WASHINGTON (AP) — U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.
Recent Comments